Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis Marko LucijanicIvan KrecakRajko Kusec Correspondence 23 April 2024 Pages: 2157 - 2159
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis Chih-Cheng ChenJustin L. ChenHsin-An Hou Research Open access 23 April 2024 Pages: 1947 - 1965
SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports Ryohei OnoIzumi Kitagawa Review 23 April 2024
Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells Yanyan ZhangFen HeJiliang Xia Research 22 April 2024
Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia Shanshan QinYingxin JiangYunfeng Cheng Original Article 22 April 2024
Multi-center study of COVID-19 infection in elderly patients with lymphoma: on behalf of Jiangsu Cooperative Lymphoma Group (JCLG) Huayuan ZhuXiao LuWenyu Shi Research 22 April 2024
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel Julie KanterKenneth I. AtagaMichael S. Broder Original Article 20 April 2024 Pages: 1909 - 1917
Diagnosing aceruloplasminemia: navigating through red herrings Zeni KharelHimal KharelPradyumna D. Phatak Case Report 19 April 2024 Pages: 2173 - 2176
Psychological and physical side effects during G-CSF mobilization in related donors of allo-HCT Lingxia CaiDiange JinYishan Ye Research 19 April 2024
Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial Aishwarya AnandNaveen C HegdeSamir Malhotra Research 18 April 2024 Pages: 2133 - 2144
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML Akriti G JainQuinto GesiottoKendra Sweet Research Open access 18 April 2024 Pages: 1941 - 1945
COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study Sophie ThauChristian Bjørn PoulsenLars Møller Pedersen Research Open access 18 April 2024
Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies Lourdes CordónPedro ChorãoJaime Sanz Research 18 April 2024
Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia Daniel Zechariah Paul JebanesanRaveen Stephen Stallon IllangeswaranPoonkuzhali Balasubramanian Original Article 17 April 2024 Pages: 1919 - 1929
Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report Gurjeet BhanguKelsey UminskiNatalia Rydz Letter to the Editor 17 April 2024
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey Andrea DuminucoAlessandra RomanoCarlo Visco Research 17 April 2024
Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines Charalampos CharalampousDarshi ShahRajshekhar Chakraborty Review 17 April 2024
A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs Fuxin MaZhiwei ZengJinhua Zhang Research 17 April 2024
Comparison of human leukocyte antigen in patients with paroxysmal nocturnal hemoglobinuria of different clone sizes Zhuxin ZhangQinglin HuBing Han Original Article 15 April 2024 Pages: 1897 - 1907
Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture Katsuyoshi ShimozawaHiroshi YagasakiIchiro Morioka Correspondence 13 April 2024 Pages: 2161 - 2162
Therapeutic progress in relapsed/refractory multiple myeloma Qi ChenMin ZhangYamin Tan Review Article 13 April 2024 Pages: 1833 - 1841
Post-transplant lymphoproliferative disease of two different histological types Takashi OnakaKoichi OhshimaAkihito Yonezawa Dear Editor, 13 April 2024
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study Salvatore LeottaUros MarkovicGiuseppe Milone Research 13 April 2024
Loss of NLRP6 expression increases the severity of intestinal injury after syngeneic hematopoietic stem cell transplantation Shengyun ZhuXue ZhangKailin Xu Research 12 April 2024
Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia/lymphoma in first complete remission: a single-center study Zhenyang GuFei LiDaihong Liu Original Article 12 April 2024
Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients Bo Kyung KimKyung Taek HongHyoung Jin Kang Original Article Open access 10 April 2024 Pages: 2051 - 2058
Could it be VEXAS? Hippolyte GuerineauMilena KohnAurélie Cabannes-Hamy Case Report 09 April 2024 Pages: 2169 - 2171
Bibliometric analysis of worldwide research on Polycythemia Vera in the 21st century Zhengjiu CuiFei LuoYueli Pan Review 09 April 2024
Thiotepa-busulfan-fludarabine-based conditioning as a promising approach prior to allogeneic hematopoietic stem cell transplantation in patients with blastic plasmacytoid dendritic cell neoplasm Xianbo HuangShasha WangJiejing Qian Case Report 08 April 2024 Pages: 2165 - 2168
Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China Lan LuoYang JiaoHongmei Jing Research 06 April 2024 Pages: 2073 - 2087
Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia Antonella MeloniLaura PistoiaFilippo Cademartiri Original Article 06 April 2024 Pages: 1887 - 1896
Quality of life after immune suppressive therapy in aplastic anemia Iris N. LommerseChris HinnenJennifer M.-L. Tjon Original Article Open access 05 April 2024 Pages: 2113 - 2121
Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma Takumi KondoKeito OharaKensuke Kojima Letter to the Editor 03 April 2024
Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study Lucía Pérez-LamasRaquel de Paz AriasValentín García-Gutiérrez Research 03 April 2024
Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report Jiawen WangHan ZhuKourong Miao Case Report 01 April 2024 Pages: 1775 - 1777
The role of therapeutic plasma exchange in plasma cell disorders Danai DimaJack Khouri Review Open access 01 April 2024
Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians Cordula GebelIsabel KruschelUlrich Wedding Research Open access 28 March 2024 Pages: 1753 - 1763
Comparison of rabbit ATLG and ATG for GVHD prophylaxis in hematological malignancies with haploidentical hematopoietic stem cell transplantation Zhengqin TianQihang ManJingbo Wang Research 28 March 2024 Pages: 1729 - 1736
Correction to: Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia Yue ChenMengge PanPeipei Xu Correction 27 March 2024 Pages: 1801 - 1801
Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation Miao ZhouTongyu LiGuifang Ouyang Original Article 27 March 2024 Pages: 1697 - 1704
Novel methyltransferase G9a inhibitor induces ferroptosis in multiple myeloma through Nrf2/HO-1 pathway Yu ZhangXiaoshun WangLijuan Wang Research 27 March 2024
The influence of hospital volume and physician volume on early mortality in acute promyelocytic leukemia patients Chia-Ying WuChiu-Mei YehChia-Jen Liu Original Article Open access 26 March 2024 Pages: 1577 - 1586
The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study Haixia FuXuan Caion behalf of the Collaborative ITP Working Group Research 25 March 2024 Pages: 1549 - 1559
Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study Alexander RöthWilma BarcelliniIlene C. Weitz Correction Open access 23 March 2024 Pages: 1803 - 1803
Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia Eduardo J. Bardón-CanchoJosé Manuel Marco-SánchezElena Cela Original Article Open access 23 March 2024 Pages: 1525 - 1539
XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute myeloid leukemia via downregulating glutathione pathway Xiaoya CaiYing LiuDengju Li Research 23 March 2024
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report Shuhei KurosawaTakako YokotaTomonori Nakazato Correspondence 21 March 2024 Pages: 1779 - 1781
Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation Yoshihiro UmezawaKota YoshifujiTakehiko Mori Research 21 March 2024 Pages: 1737 - 1744
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report Jian-hui ZhangHui ChenHong Li Case Report 20 March 2024 Pages: 1765 - 1774
